Literature DB >> 17936846

The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer.

Claudia Meissner1, Gianluca Giannarini, Martin C Schumacher, Harriet Thoeny, Urs E Studer, Fiona C Burkhard.   

Abstract

PURPOSE: We determined the efficiency of routine excretory urography for detecting tumor recurrence in the upper urinary tract after cystectomy and urinary diversion for bladder cancer.
MATERIALS AND METHODS: We evaluated 322 patients who underwent cystectomy and urinary diversion, and had undergone routine followup, including regular excretory urography 1, 2, 3, 5, 7 and 10 years after cystectomy.
RESULTS: Upper urinary tract recurrence was found in 15 of the 322 patients (4.7%) patients. Eight of 15 cases were detected by routine excretory urography, resulting in a low efficiency of 0.75% (8 of 1,064 studies) for this method. The remaining 7 recurrences were detected as a result of symptoms such as macrohematuria or flank pain occurring between routine followup examinations. Patients were at up to 10 times higher risk for recurrence in the upper urinary tract if they had positive distal ureteral resection margins or a history of upper urinary tract tumors. Although the incidence of recurrence in the upper urinary tract increased 1.8-fold in patients with pTa/pT1 tumors, it remained relatively low at 8.4%.
CONCLUSIONS: The incidence of recurrence in the upper urinary tract a median of 49 months (range 12 to 220) after cystectomy for transitional cell carcinoma was 4.7%. Because only half of these cases were detected by routine excretory urography, this should be limited to patients at high risk with a history of upper urinary tract tumors or positive ureteral margins. In the future other techniques, eg cytology of voided urine or new markers, should be evaluated to replace excretory urography for routine followup of patients after cystectomy for transitional cell carcinoma of the bladder.

Entities:  

Mesh:

Year:  2007        PMID: 17936846     DOI: 10.1016/j.juro.2007.08.041

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Upper urinary tract biopsy: an old device for a new approach.

Authors:  G Carrafiello; F Fontana; M Mangini; A M Ierardi; E Cotta; F Piacentino; M De Chiara; C Floridi; A Di Massa; A M Marconi; C Fugazzola
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

2.  A plea for a uniform surveillance schedule after radical cystectomy.

Authors:  Guido Dalbagni; Bernard H Bochner; Angel Cronin; Harry W Herr; S Machele Donat
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

3.  [Diagnostic procedures in upper urinary tract urothelial carcinoma].

Authors:  O Patschan; M Horstmann; C Thomas; H P Schlemmer; A Stenzl
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

4.  [Follow-up surveillance of muscle-invasive urinary bladder cancer after curative treatment].

Authors:  G B Schulz; C G Stief; B Schlenker
Journal:  Urologe A       Date:  2019-09       Impact factor: 0.639

5.  The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer.

Authors:  Mario I Fernández; Sahil Parikh; H Barton Grossman; Ruth Katz; Surena F Matin; Colin P N Dinney; Ashish M Kamat
Journal:  Urol Oncol       Date:  2011-03-10       Impact factor: 3.498

Review 6.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

7.  Survival impact of followup care after radical cystectomy for bladder cancer.

Authors:  Seth A Strope; Su-Hsin Chang; Ling Chen; Gurdarshan Sandhu; Jay F Piccirillo; Mario Schootman
Journal:  J Urol       Date:  2013-05-29       Impact factor: 7.450

8.  Monitoring of the upper urinary tract in patients with bladder cancer.

Authors:  Rajinikanth Ayyathurai; Mark S Soloway
Journal:  Indian J Urol       Date:  2011-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.